Cost of Illness in Patients With COVID-19 Admitted in three Brazilian Public Hospitals

Página do item simplificado
dc.contributor.authorOliveira, Layssa Andrade
dc.contributor.authorLucchetta, Rosa Camila [UNESP]
dc.contributor.authorMendes, Antônio Matoso
dc.contributor.authorBonetti, Aline de Fátima
dc.contributor.authorXavier, Cecilia Silva [UNESP]
dc.contributor.authorSanches, Andréia Cristina Conegero
dc.contributor.authorBorba, Helena Hiemisch Lobo
dc.contributor.authorOliota, Ana Flávia Redolfi
dc.contributor.authorRossignoli, Paula
dc.contributor.authorMastroianni, Patrícia de Carvalho [UNESP]
dc.contributor.authorVenson, Rafael
dc.contributor.authorVirtuoso, Suzane
dc.contributor.authorde Nadai, Tales Rubens [UNESP]
dc.contributor.authorWiens, Astrid
dc.contributor.institutionFederal University of Paraná
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionHospital Alemão Oswaldo Cruz
dc.contributor.institutionClinics Hospital Complex of the Federal University of Paraná
dc.contributor.institutionState University of Western Paraná
dc.contributor.institutionParaná State Health Department
dc.contributor.institutionUniversity of Glasgow
dc.date.accessioned2023-07-29T16:09:51Z
dc.date.available2023-07-29T16:09:51Z
dc.date.issued2023-07-01
dc.description.abstractObjectives: The severity and transmissibility of COVID-19 justifies the need to identify the factors associated with its cost of illness (CoI). This study aimed to identify CoI, cost predictors, and cost drivers in the management of patients with COVID-19 from hospital and Brazil's Public Health System (SUS) perspectives. Methods: This is a multicenter study that evaluated the CoI in patients diagnosed of COVID-19 who reached hospital discharge or died before being discharged between March and September 2020. Sociodemographic, clinical, and hospitalization data were collected to characterize and identify predictors of costs per patients and cost drivers per admission. Results: A total of 1084 patients were included in the study. For hospital perspective, being overweight or obese, being between 65 and 74 years old, or being male showed an increased cost of 58.4%, 42.9%, and 42.5%, respectively. From SUS perspective, the same predictors of cost per patient increase were identified. The median cost per admission was estimated at US$359.78 and US$1385.80 for the SUS and hospital perspectives, respectively. In addition, patients who stayed between 1 and 4 days in the intensive care unit (ICU) had 60.9% higher costs than non-ICU patients; these costs significantly increased with the length of stay (LoS). The main cost driver was the ICU-LoS and COVID-19 ICU daily for hospital and SUS perspectives, respectively. Conclusions: The predictors of increased cost per patient at admission identified were overweight or obesity, advanced age, and male sex, and the main cost driver identified was the ICU-LoS. Time-driven activity-based costing studies, considering outpatient, inpatient, and long COVID-19, are needed to optimize our understanding about cost of COVID-19.en
dc.description.affiliationPostgraduate Program in Pharmaceutical Science Federal University of Paraná
dc.description.affiliationSchool of Pharmaceutical Sciences São Paulo State University
dc.description.affiliationSustainability and Social Responsibility Hospital Alemão Oswaldo Cruz
dc.description.affiliationClinics Hospital Complex of the Federal University of Paraná
dc.description.affiliationCenter for Medical and Pharmaceutical Sciences State University of Western Paraná
dc.description.affiliationPharmacy Department Federal University of Paraná
dc.description.affiliationDepartment of Pharmaceutical Assistance Paraná State Health Department
dc.description.affiliationSchool of Medicine Dentistry and Nursing University of Glasgow, Scotland
dc.description.affiliationDepartment of Public Health Faculty of Dentistry of Bauru São Paulo State University
dc.description.affiliationUnespSchool of Pharmaceutical Sciences São Paulo State University
dc.description.affiliationUnespDepartment of Public Health Faculty of Dentistry of Bauru São Paulo State University
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.format.extent34-43
dc.identifierhttp://dx.doi.org/10.1016/j.vhri.2023.02.004
dc.identifier.citationValue in Health Regional Issues, v. 36, p. 34-43.
dc.identifier.doi10.1016/j.vhri.2023.02.004
dc.identifier.issn2212-1102
dc.identifier.issn2212-1099
dc.identifier.scopus2-s2.0-85151400609
dc.identifier.urihttp://hdl.handle.net/11449/249810
dc.language.isoeng
dc.relation.ispartofValue in Health Regional Issues
dc.sourceScopus
dc.subjectcost analysis
dc.subjectcost of illness
dc.subjectCOVID-19
dc.subjecthospital care
dc.subjecthospital costs
dc.titleCost of Illness in Patients With COVID-19 Admitted in three Brazilian Public Hospitalsen
dc.typeArtigo
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos

Coleções

Araraquara - FCF - Faculdade de Ciências Farmacêuticas